Insider Transactions in Q2 2021 at Certara, Inc. (CERT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,000
-0.85%
|
$84,000
$28.38 P/Share
|
|
Jun 24
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
5,000
-1.4%
|
$130,000
$26.37 P/Share
|
|
Jun 23
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
75,000
-1.13%
|
$1,950,000
$26.85 P/Share
|
|
Jun 22
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
66,666
-7.43%
|
$1,733,316
$26.94 P/Share
|
|
Jun 16
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
SELL
Open market or private sale
|
Direct |
5,000
-1.11%
|
$135,000
$27.02 P/Share
|
|
Jun 15
2021
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+50.0%
|
-
|
|
Jun 14
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
SELL
Open market or private sale
|
Direct |
19,354
-2.49%
|
$522,558
$27.8 P/Share
|
|
Jun 11
2021
|
Craig R. Rayner PRESIDENT, INTEGRATED DRUG DEV |
SELL
Open market or private sale
|
Direct |
108,924
-8.06%
|
$2,832,024
$26.0 P/Share
|
|
May 18
2021
|
James E Cashman Iii |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+1.44%
|
-
|
|
May 18
2021
|
Sherilyn S Mc Coy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+1.12%
|
-
|
|
May 18
2021
|
Mason P Slaine |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+0.26%
|
-
|
|
May 18
2021
|
Matthew M Walsh |
BUY
Grant, award, or other acquisition
|
Direct |
7,059
+3.77%
|
-
|
|
Apr 01
2021
|
Robert Aspbury PRESIDENT, SCIENTIFIC SOFTWARE |
BUY
Grant, award, or other acquisition
|
Direct |
18,315
+4.47%
|
-
|
|
Apr 01
2021
|
Jieun W. Choe CHIEF STRATEGY & MARKETING |
BUY
Grant, award, or other acquisition
|
Direct |
18,315
+5.07%
|
-
|
|
Apr 01
2021
|
Judith Dickinson Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,905
+6.42%
|
-
|
|
Apr 01
2021
|
Richard M. Traynor SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
16,484
+4.4%
|
-
|
|
Apr 01
2021
|
William F Feehery CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
91,575
+2.69%
|
-
|
|
Apr 01
2021
|
Craig R. Rayner PRESIDENT, INTEGRATED DRUG DEV |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+4.87%
|
-
|
|
Apr 01
2021
|
Michael Andrew Schemick CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,799
+3.74%
|
-
|
|
Apr 01
2021
|
Justin Edge PRES., REGULATORY & ACCESS |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+5.0%
|
-
|
|
Apr 01
2021
|
Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF |
BUY
Grant, award, or other acquisition
|
Direct |
23,810
+7.84%
|
-
|